Henry Schein Inc. ($HSIC) Stock Forecast: Down 5.1% Today

What is Henry Schein Inc.?

Henry Schein Inc. operates in the healthcare industry, specializing in dental and medical supplies. The stock saw a notable decline in value recently.

Why is Henry Schein Inc. going down?

HSIC stock is down 5.1% on May 7, 2026 14:26

• Despite posting robust Q1 2026 earnings and surpassing projections, HSIC stock performed below expectations, ending the day 18.87% lower than its highest value in the past year.
• Market comparisons with industry peers and broader market indices might have influenced the stock's downward trend.
• The subdued performance in the medical sector, attributed to a mild flu season, could have affected investor confidence, despite the company's efforts to enhance its value proposition.
• Variations in HSIC's performance relative to competitors on different trading days indicate the significant impact of market sentiment and external factors on the recent decline.

HSIC Price Chart

HSIC Technical Analysis

HSIC News

Henry Schein Inc. stock underperforms Wednesday when compared to competitors

Henry Schein Inc. (HSIC) stock fell 2.60% to $72.44 on Wednesday, underperforming the broader market. This occurred despite positive trading sessions for the S&P 500 Index and the Dow Jones Industrial Average. The company's stock closed 18.87% below its 52-week high.

https://www.marketwatch.com/data-news/henry-schein-inc-stock-underperforms-wednesday-when-compared-to-competitors-fee7894a-ff0b5dd043f9

Henry Schein, Inc. (NASDAQ:HSIC) Q1 2026 Earnings Call Transcript

Henry Schein, Inc. reported strong first-quarter 2026 results, beating earnings expectations with an EPS of $1.32 against an expected $1.20. The company highlighted strong performance in U.S. dental and global technology businesses, offsetting softness in medical due to a light flu season. CEO Fred Lowery emphasized progress on value creation initiatives aimed at achieving over $200 million in annual operating income improvement and sustained high single-digit to low double-digit earnings growth.

https://www.insidermonkey.com/blog/henry-schein-inc-nasdaqhsic-q1-2026-earnings-call-transcript-1754826/

[10-Q] DENTSPLY SIRONA Inc. Quarterly Earnings Report

DENTSPLY SIRONA Inc. (XRAY) reported its Q1 2026 earnings, showing a net loss of $10 million compared to a net income of $19 million in Q1 2025. The company's net sales remained flat year-over-year at $880 million, with a decrease in gross profit margin. The report highlights increased R&D expenses, significant restructuring costs, and ongoing litigation challenges, reflecting a period of strategic adjustments and operational focus amid global economic uncertainties.

https://www.stocktitan.net/sec-filings/XRAY/10-q-dentsply-sirona-inc-quarterly-earnings-report-4c71fcd13086.html

Henry Schein Inc. stock outperforms competitors on strong trading day

Shares of Henry Schein Inc. (HSIC) rose 3.26% to $74.37 on Tuesday, outperforming the broader market indexes like the S&P 500 and Dow Jones Industrial Average. This increase broke a two-day losing streak for the company's stock. The positive performance occurred during an overall strong trading day for the stock market.

https://www.marketwatch.com/data-news/henry-schein-inc-stock-outperforms-competitors-on-strong-trading-day-67eed8f0-64cf2b0316ae?mod=mw_quote_news

Cencora to Report Q2 Earnings: What's in Store for the Stock?

Cencora (COR) is set to report its fiscal second-quarter 2026 results on May 6. Analysts anticipate revenues of $80.76 billion, up 7% year-over-year, and earnings of $4.81 per share, representing an 8.8% improvement. While the company expects strong growth in specialty pharmaceuticals and its U.S. distribution business, the Zacks Model does not conclusively predict an earnings beat, with an Earnings ESP of -0.80% and a Zacks Rank #4 (Sell).

https://au.finance.yahoo.com/news/cencora-report-q2-earnings-whats-143200190.html

Trending Today

NASDAQ-100 ($NDX) Index Forecast: Down 0.6% Today

Medtronic plc. ($MDT) Stock Forecast: Up 5.0% Today

SL Green Realty Corp ($SLG) Stock Forecast: Up 5.1% Today

SBA Communications Corporation ($SBAC) Stock Forecast: Up 5.0% Today

Arista Networks Inc. ($ANET) Stock Forecast: Down 5.1% Today

Virgin Galactic Holdings Inc ($SPCE) Stock Forecast: Up 12.6% Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Up 8.9% Today

Centene Corporation ($CNC) Stock Forecast: Up 5.6% Today

Crown Castle International Corp. (REIT) ($CCI) Stock Forecast: Up 5.2% Today

UnitedHealth Group Incorporated (DE) ($UNH) Stock Forecast: Up 5.2% Today

Henry Schein Inc. Price History

24.01.2026 - HSIC Stock was up 9.7%

• Strong fourth-quarter results, surpassing analyst expectations for both earnings and revenue, contributed to the bullish market movement.
• An optimistic fiscal 2026 outlook, forecasting adjusted EPS between $5.23 and $5.37 and total sales growth of 3% to 5%, further fueled investor confidence in the company.
• The positive reception of biosimilars in the healthcare industry may have also boosted sentiment towards Henry Schein, given its involvement in the medical supplies sector.
• The combination of robust financial performance and positive industry trends likely drove the bullish movement in Henry Schein's stock today.

24.01.2026 - HSIC Stock was up 6.7%

• HSIC stock experienced a bullish movement, jumping over 8% following the release of its Q4 earnings report, which beat analyst estimates for both earnings and sales.
• Despite missing EPS estimates, the company's revenue growth across various segments, such as Dental, Medical, Specialty Products, and Technology, contributed to the positive market sentiment.
• The contraction in margins due to increased costs of sales and expenses might be a concern for investors, but the overall strong financial performance and revenue beats likely drove the stock price higher.
• The broader market trend of U.S. stocks seeing gains on Tuesday, coupled with positive quarterly results from multiple companies, contributed to the bullish movement in Henry Schein's stock.

04.10.2025 - HSIC Stock was up 13.7%

• HSIC stock experienced a strong bullish movement today following the release of their Q3 earnings report.
• The earnings and revenue beats by +8.66% and +2.02% respectively have exceeded market expectations, indicating strong performance by the company.
• Investors are likely optimistic about the future prospects of HSIC, as the positive results suggest continued growth and profitability in the healthcare industry.
• The beat in earnings and revenues could attract more investors to the stock, driving up demand and pushing the stock price higher.

04.10.2025 - HSIC Stock was up 10.4%

• HSIC stock saw a surge following the announcement of better-than-expected Q3 earnings and revenue, exceeding analyst estimates by a notable margin.
• Boosting investor confidence, the company's decision to raise its 2025 outlook due to solid business momentum played a significant role in the stock's upward movement.
• The positive surprises in earnings and revenue point towards robust performance and growth potential for Henry Schein, eliciting increased optimism among investors and driving the stock price higher.

25.01.2026 - HSIC Stock was down 6.8%

• A price target increase for Henry Schein to $100 from $90 by Evercore ISI could have initially boosted investor confidence, but the market sentiment shifted bearish despite this positive adjustment.
• Although the company demonstrated strong sales growth in dental and specialty products, concerns about the thin net margin and premium P/E ratio may have led to a bearish movement in the stock.
• The market's response to Henry Schein's better-than-expected fourth-quarter revenue but earnings miss suggests that investors are focusing more on profitability metrics, contributing to the bearish trend.
• The positive financial guidance for 2026 and share repurchase activities might not have been sufficient to offset concerns about the company's profitability and valuation, resulting in the bearish market movement.

15.00.2026 - HSIC Stock was up 3.9%

• The appointment of Frederick M. Lowery, a seasoned executive with a background in the healthcare industry, as the new CEO of Henry Schein has brought a fresh perspective to the company's leadership.
• The strategic shift in leadership, with Stanley M. Bergman transitioning to Chairman, signifies a governance reframe that aims to drive operational efficiencies and growth in specialty products and technology.
• Investors seem optimistic about the potential impact of the new CEO's expertise in distribution and product businesses on Henry Schein's strategic goals, leading to a bullish market movement for the stock.

07.04.2026 - HSIC Stock was down 5.1%

• Despite posting robust Q1 2026 earnings and surpassing projections, HSIC stock performed below expectations, ending the day 18.87% lower than its highest value in the past year.
• Market comparisons with industry peers and broader market indices might have influenced the stock's downward trend.
• The subdued performance in the medical sector, attributed to a mild flu season, could have affected investor confidence, despite the company's efforts to enhance its value proposition.
• Variations in HSIC's performance relative to competitors on different trading days indicate the significant impact of market sentiment and external factors on the recent decline.

05.04.2026 - HSIC Stock was down 0.3%

• Despite recording strong Q1 2026 financial results, which included a 6.3% increase in sales surpassing analyst expectations, Henry Schein's stock witnessed a slight decline.
• The market's reaction may have been influenced by concerns regarding the company's soft medical business performance and a decrease in adjusted operating margin, despite the overall positive results.
• Investor caution may stem from the modest organic revenue growth and the decrease in free cash flow, leading to a bearish sentiment despite the company's reaffirmed financial guidance and efforts to create value.
• The slight dip in after-hours trading could also be linked to investors taking profits following the positive earnings announcement, contributing to the bearish movement in HSIC stock.